Patents/Assignees

Enveric Biosciences Canada Inc.

26 patents in portfolio

US12605361utility2026
Carboxylated Psilocybin Derivatives and Methods of Using
0 cites
US12577232utility2026
N-heterocycle Substituted Tryptamine Derivatives and Methods of Using
0 cites
US12492179utility2025
Substituted Ethylamine Fused Heterocyclic Mescaline Derivatives
0 cites
US12428408utility2025
Fused Heterocyclic Mescaline Derivatives
0 cites
US12378195utility2025
Aminated Psilocybin Derivatives and Methods of Using
0 cites
US12358885utility2025
Substituted N-propylamine Fused Heterocyclic Mescaline Derivatives
0 cites
US12338231utility2025
N-heterocycle Substituted Tryptamine Derivatives and Methods of Using
0 cites
US12195439utility2025
C1-substituted Isopropylamine Fused Heterocyclic Mescaline Derivatives
0 cites
US12187679utility2025
Hydroxylated Psilocybin Derivatives and Methods of Using
0 cites
US12138276utility2024
Halogenated Psilocybin Derivatives and Methods of Using
0 cites
US12133856utility2024
Multi-substituent Psilocybin Derivatives and Methods of Using
0 cites
US12128058utility2024
Multi-substituent Psilocybin Derivatives and Methods of Using
0 cites
US12077498utility2024
C4-carboxylic Acid-substituted Tryptamine Derivatives and Methods of Using
0 cites
US12065404utility2024
C4-carboxylic Acid-substituted Tryptamine Derivatives and Methods of Using
0 cites
US11998557utility2024
Halogenated Psilocybin Derivatives and Methods of Using
0 cites
US11945778utility2024
C 4 -carbonothioate-substituted Tryptamine Derivatives and Methods of Using
0 cites
US11931338utility2024
Nitrilated Psilocybin Derivatives and Methods of Using
0 cites
US11918594utility2024
Multi-substituent Psilocybin Derivatives and Methods of Using
0 cites
US11891359utility2024
Prenylated Psilocybin Derivatives and Methods of Using
0 cites
US11891360utility2024
Glycosylated Psilocybin Derivatives and Methods of Using
0 cites

Page 1 of 2Next →